是否MUC5B rs35705950促进物多态性与慢性肺异位移植功能障碍有关?
Adèle Sandot1,2, Ibrahima Ba1,3, Clément R Massonnaud4,5
1Université Paris Cité, PHERE UMRS 1152, Paris, France.
ERJ open research
|October 29, 2025
概括
肺移植接受者或捐赠者的MUC5B rs35705950多态性不会影响慢性肺移植异位功能障碍 (CLAD) 的结果. 然而,接受者MUC5B基因型可能会降低抗体介导排斥 (AMR) 风险.
科学领域:
- 肺部医学 肺部医学
- 移植免疫学 移植免疫学
- 遗传学 是一个遗传学.
背景情况:
- 慢性肺异位移植功能障碍 (CLAD) 是肺移植 (LT) 后死亡的主要原因.
- 对于CLAD的潜在病理生理学和风险因素尚未完全理解,有来自捐赠者或接受者的潜在遗传影响.
- MUC5B促进体rs35705950多态性是一种已知与肺纤维化相关的遗传因素.
研究的目的:
- 研究肺移植接受者和捐赠者的MUC5B rs35705950多态性之间的关联及其对LT结果的影响.
- 确定这种遗传多态化是否影响了CLAD.的发展或表型.
- 探索MUC5B基因型与抗体介导排斥 (AMR) 的发生之间的潜在相关性.
主要方法:
- 从肺移植生物库中的队列中分析接受者和捐赠者血液样本.
- 使用定量PCR确定MUC5B rs35705950多态状态.
- 在210个接受者-捐赠者对中盲目判断CLAD发生率和表型.
主要成果:
- 在捐赠者或接受者中,MUC5B rs35705950多态性与5年后的CLAD,无CLAD存活率或CLAD表型没有显著的关联.
- 接受者的T等位基因的患病率在不同的潜在呼吸系统疾病 (例如,间歇性肺病,肺气,囊性纤维化) 中有显著的差异.
- 虽然捐赠者的MUC5B基因型没有影响AMR风险,但接受者的T等位基因存在与AMR发生率的减少有关 (OR0.26,p=0.015).
结论:
- 捐赠者或接受者的MUC5B rs35705950多态性似乎不会影响与CLAD相关的整体肺移植结果.
- 接受者的MUC5B多态性和AMR发病率较低之间的潜在保护性关联需要进一步调查和确认.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Cystic Fibrosis: Pathogenesis
703
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
703
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K


